Reply to thread

Message

[QUOTE="Munyaradzi Mafaro, post: 61043, member: 636"]
President Trump declared tariffs of 100 percent on branded and patented drug imports. Companies must start manufacturing plants in America before October 1st to avoid these penalties. Building projects already breaking ground will receive exemptions from the new trade restrictions.

Indian political figures responded with mixed reactions to the pharmaceutical trade policy. UP Minister Narendra Kashyap dismissed concerns about economic damage to the nation. Congress representatives criticized Prime Minister Modi for remaining silent on the announcement. Opposition members warned that medicine manufacturers face potential business failure under the new tariff structure.

India exports significant quantities of generic and branded medications worldwide. The trade policy threatens serious economic consequences for the pharmaceutical sector. Congress leader Udit Raj expressed alarm over the sudden policy change affecting medicine trade relationships.
[/QUOTE]

Name